View in EDS HTML Full Text PDF Full Text

CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.

Saved in:

Bibliographic Details
Title:	CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.
Authors:	Ghaffari, Sasan^1,2 (AUTHOR), Khalili, Nastaran¹ (AUTHOR), Rezaei, Nima^3,4,5 (AUTHOR) rezaei_nima@yahoo.com
Source:	Journal of Experimental & Clinical Cancer Research (17569966). 8/26/2021, Vol. 40 Issue 1, p1-18. 18p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17569966
DOI:	10.1186/s13046-021-02076-5